scholarly article | Q13442814 |
P50 | author | Stephen Stahl | Q24006564 |
P2093 | author name string | Thomas L Schwartz | |
Shilpa Sachdeva | |||
P433 | issue | 12 | |
P921 | main subject | schizophrenia | Q41112 |
P304 | page(s) | 1580-1592 | |
P577 | publication date | 2012-01-01 | |
P1433 | published in | Current Pharmaceutical Design | Q5195068 |
P1476 | title | Genetic data supporting the NMDA glutamate receptor hypothesis for schizophrenia | |
P478 | volume | 18 |
Q33607904 | A Neurophysiological Perspective on a Preventive Treatment against Schizophrenia Using Transcranial Electric Stimulation of the Corticothalamic Pathway |
Q38122300 | A systematic review of the effects of NMDA receptor antagonists on oscillatory activity recorded in vivo |
Q34283319 | Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap. |
Q35626044 | Altered neuronal excitability underlies impaired hippocampal function in an animal model of psychosis |
Q39580232 | Beyond dopamine: glutamate as a target for future antipsychotics. |
Q38024032 | Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins. |
Q37561567 | Cortical synaptic NMDA receptor deficits in α7 nicotinic acetylcholine receptor gene deletion models: implications for neuropsychiatric diseases. |
Q38820530 | DNA Damage in Major Psychiatric Diseases |
Q35699606 | Differential Effects of D-Cycloserine and ACBC at NMDA Receptors in the Rat Entorhinal Cortex Are Related to Efficacy at the Co-Agonist Binding Site |
Q61814348 | EEG 40 Hz Coherence Decreases in REM Sleep and Ketamine Model of Psychosis |
Q38063195 | Glutamate neurocircuitry: theoretical underpinnings in schizophrenia |
Q24202544 | Memantine for schizophrenia |
Q52648016 | Metabolomic profiling of schizophrenia patients at risk for metabolic syndrome. |
Q30397669 | NMDA Receptors Mediate Stimulus-Timing-Dependent Plasticity and Neural Synchrony in the Dorsal Cochlear Nucleus |
Q54989276 | Study of the Effect of Memantine on Negative Sign in Patients with Schizophrenia and Schizoaffective Disorders. |
Q39020275 | Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system |
Q38223276 | Targeting of NMDA receptors in new treatments for schizophrenia |
Q48138640 | The effects of N-Methyl-D-Aspartate receptor blockade during the early neurodevelopmental period on emotional behaviors and cognitive functions of adolescent Wistar rats |
Q38213709 | The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatment |
Q38232366 | The neurobiology and treatment of first-episode schizophrenia |
Search more.